Omeros (OMER) Other Non-Current Liabilities (2021 - 2026)

Omeros (OMER) reported Other Non-Current Liabilities of $84.0 million for Q1 2026, up 1766.81% on a YoY basis from $4.5 million in Q1 2025, and down 46.54% sequentially from $157.2 million in Q4 2025.

Omeros (OMER) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

Omeros (OMER) has 6 years of Other Non-Current Liabilities data on file, last reported at $84.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Liabilities rose 1766.81% year-over-year to $84.0 million; the trailing twelve-month figure through Mar 2026 stood at $84.0 million (up 1766.81% YoY), and the FY2025 full-year result was $157.2 million, up 3391.91% from the prior year.
  • Other Non-Current Liabilities retreated to $84.0 million in Q1 2026, from $157.2 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $157.2 million in Q4 2025 to a low of $444000.0 in Q4 2022.
  • A 5-year average of $17.1 million and a median of $2.1 million in 2023 frame the typical range for Other Non-Current Liabilities.
  • Across the five-year window, Other Non-Current Liabilities slumped 60.18% in 2022 and soared 3391.91% in 2025, its largest moves.
  • Tracing OMER's Other Non-Current Liabilities over 5 years: stood at $444000.0 in 2022, then surged by 370.27% to $2.1 million in 2023, then surged by 115.57% to $4.5 million in 2024, then soared by 3391.91% to $157.2 million in 2025, then slumped by 46.54% to $84.0 million in 2026.
  • Business Quant data shows OMER's Other Non-Current Liabilities at $84.0 million in Q1 2026, $157.2 million in Q4 2025, and $4.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Omeros 739.31 Mn 739.31 Mn 9.31 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 84.03 Mn
Dec 31, 2025 157.17 Mn
Sep 30, 2025 4.50 Mn
Jun 30, 2025 4.50 Mn
Mar 31, 2025 4.50 Mn
Dec 31, 2024 4.50 Mn
Sep 30, 2024 3.09 Mn
Jun 30, 2024 2.09 Mn
Mar 31, 2024 2.09 Mn
Dec 31, 2023 2.09 Mn
Jun 30, 2023 496,000.00
Mar 31, 2023 452,000.00
Dec 31, 2022 444,000.00
Sep 30, 2022 999,000.00
Jun 30, 2022 961,000.00
Mar 31, 2022 922,000.00
Dec 31, 2021 1.12 Mn